Minirin and Movicol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minirin (desmopressin acetate) and Movicol (polyethylene glycol 3350). Common drug interactions include nausea among females and agitation among males.

The phase IV clinical study analyzes what interactions people have when they take Minirin and Movicol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Minirin?

Minirin has active ingredients of desmopressin acetate. It is often used in diabetes insipidus. eHealthMe is studying from 1,364 Minirin users. Check the latest studies of Minirin.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.



On Jul, 25, 2026

12 people who take Minirin and Movicol together, and have interactions are studied.

Minirin and Movicol drug interactions.

What are the common drug interactions of Minirin and Movicol, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Overdose
  3. Vomiting
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Confusional state

male:

  1. Agitation (state of anxiety or nervous excitement)
  2. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  3. Anxiety
  4. Body temperature increased
  5. Drug ineffective
  6. Muscle rigidity (muscle stiffness)
  7. Renal failure (kidney dysfunction)
  8. Urinary tract infection

What are the common drug interactions of Minirin and Movicol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Agitation (state of anxiety or nervous excitement)
  2. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  3. Nausea (feeling of having an urge to vomit)
  4. Overdose
  5. Vomiting
  6. Anxiety
  7. Body temperature increased
  8. Drug ineffective
  9. Muscle rigidity (muscle stiffness)
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 7 people, 58.33%
  2. Anaemia (lack of blood): 2 people, 16.67%
  3. Abnormal Behavior: 2 people, 16.67%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 8.33%
  5. Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 1 person, 8.33%
  6. Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Minirin and Movicol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Minirin and Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Minirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Movicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on desmopressin acetate and polyethylene glycol 3350 (the active ingredients of Minirin and Movicol, respectively), and Minirin and Movicol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: